RT @sclerodermaUM: Please join #ACR20 for late breaking abstract on Ziritaxestat, selective autotaxin inhibitor. Phase

Social Author Image
https://pbs.twimg.com/profile_images/1037354464095731712/Fuue4WQS.jpg
Tweet Author
sclerodermaUM
Social Author Name
Dr. Dinesh Khanna
Tweet Content
Please join #ACR20 for late breaking abstract on Ziritaxestat, selective autotaxin inhibitor. Phase 2a trial with stats significant effect on skin score and well tolerated. @UMIntMed Session Date Monday, November 9 Presentation Time: 12:15 PM - 12:30 PM ET
Show on Archive Page
On
Display in Search Results
On

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright {{ 'now'|date('Y') }} All Rights Reserved.